NEWS
August 13, 2025
Avista Therapeutics and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership
April 30, 2025
Avista Therapeutics Presents In Vivo Data for its AAV Capsid in Inherited Retinal Diseases at Association for Research in Vision and Ophthalmology 2025 Annual Meeting
April 30, 2025
Avista Therapeutics Announces Oral Presentation at ARVO 2025 Annual Meeting
Jan. 7, 2025
Avista Therapeutics Appoints Steven Altschuler, MD, as Chairman of the Board of Directors
July 20, 2022
Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular Diseases